Hostname: page-component-669899f699-chc8l Total loading time: 0 Render date: 2025-04-24T14:13:00.480Z Has data issue: false hasContentIssue false
  • English
  • Français

Acute myocarditis in a paediatric patient with pre-existing dilated cardiomyopathy following SARS-COV-2 infection: a journey from decompensation to heart transplantation

Published online by Cambridge University Press:  07 November 2024

Joana Suarez Open the ORCID record for Joana Suarez [Opens in a new window] ,
Isabel Menezes ,
Maria João Brito  and
Sérgio Larango
Joana Suarez*
Affiliation:
Hospital of Santa Marta, Paediatric Cardiology, Lisboa, Portugal
Isabel Menezes
Affiliation:
Hospital de Santa Cruz, Paediatric Cardiology, Carnaxide, Portugal
Maria João Brito
Affiliation:
Hospital Dona Estefania, Pediatric Infectious Diseases, Lisboa, Portugal
Sérgio Larango
Affiliation:
Hospital of Santa Marta, Paediatric Cardiology, Lisboa, Portugal
*
Corresponding author: Joana Suarez; Email: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

A 10-year-old child with stabilised idiopathic dilated cardiomyopathy was admitted to the hospital with sudden worsening of heart failure. Further analysis showed increased NT-proBNP and positive for COVID-19. Myocarditis secondary to COVID-19 was assumed. Recurrent hospitalizations with inotropic support were required due to the progressive worsening of cardiac function. Seven months after SARS-CoV-2 myocarditis, she underwent heart transplantation.

Keywords

MyocarditisCOVID-19heart transplantationdilated cardiomyopathy
Type
Brief Report
Information
Cardiology in the Young , Volume 34 , Issue 10 , October 2024 , pp. 2244 - 2247
Check for updates
Copyright
© The Author(s), 2024. Published by Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

Sandeep, N, Fairchok, MP, Hasbani, K. Myocarditis After COVID-19 Vaccination in Pediatrics: A Proposed Pathway for Triage and Treatment. J Am Heart Assoc 2022; 11: e026097.Google Scholar
Pomiato, E, Perrone, MA, Palmieri, R, Gagliardi, MG. Pediatric Myocarditis: What Have We Learnt So Far? J Cardiovasc Dev Dis 2022; 9: 143.Google Scholar
Butbul Aviel, Y, Hashkes, PJ, Dizitzer, Y et al. Case series of myocarditis following mRNA COVID vaccine compared to pediatric multisystem inflammatory syndrome: multicenter retrospective study. Vaccines 2022; 10: 1207.CrossRefGoogle ScholarPubMed
Seidel, F, Laser, KT, Klingel, K et al. Pathogenic variants in cardiomyopathy disorder genes underlie pediatric myocarditis—further impact of heterozygous immune disorder gene variants? J Cardiovasc Dev Dis 2022; 9: 216.Google ScholarPubMed
Maunier, L, Charbel, R, Lambert, V et al. Anakinra in pediatric acute fulminant myocarditis. Ann Intensive Care, 2022; 12: 80.Google Scholar
Kindermann, I, Barth, C, Mahfoud, F et al . Update on Myocarditis. J Am Coll Cardiol 2012; 59: 779–792.CrossRefGoogle Scholar
Sagar, S, Liu, PP, Cooper, LT Jr. Myocarditis.Lancet 2012; 379: 738–747.Google Scholar
Childs, H, Friedrich, MG. Cardiovascular magnetic resonance imaging in myocarditis.Prog Cardiovasc Dis 2011; 54: 266–275.CrossRefGoogle Scholar
Friedrich, MG, Sechtem, U, Schulz-Menger, J et al . Cardiovascular magnetic resonance in myocarditis: a JACC white paper. J Am Coll Cardiol 2009; 53: 1475–1487.CrossRefGoogle ScholarPubMed
Sleem, B, Zareef, R, Bitar, F, Arabi, M. Myocarditis in COVID-19: a focus on the pediatric population. Am J Cardiovasc Dis 2023; 13: 138–151.Google ScholarPubMed
McMurray, JC, May, JW, Cunningham, MW, Jones, OY. Multisystem Inflammatory Syndrome in Children (MIS-C), a post-viral myocarditis and systemic vasculitis—A critical review of Its pathogenesis and treatment, Front Pediatr 2020; 8: 626182.Google Scholar
Boehmer, TK, Kompaniyets, L, Lavery, AM et al. Association between COVID-19 myocarditis using hospital-based administrative data—United States, March 2020–January 2021. MMWR 2021; 70: 1128–1132.Google ScholarPubMed
Mangini, F, Bruno, E, Caramia, R. Effectiveness of levosimendan and role of cardiac magnetic resonance in cardiogenic shock due to COVID-19 related lymphocytic myocarditis in the course of viral sepsis. Arch Clin Case 2023; 10: 32–38.CrossRefGoogle Scholar
Keramari, S, Poutoglidis, A, Chatzis, S, Keramaris, M, Savopoulos, C, Kaiafa, G. Parvovirus B19-Associated Myocarditis: A Literature Review of Pediatric Cases. Cureus 2022; 14: e21726.Google ScholarPubMed